Pablo Aschner

Effect of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin as Monotherapy on Glycemic Control in Patients With Type 2 Diabetes

Pablo Aschner, Mark Kipnes, Jared Lunceford et al. · Diabetes Care · 2006 · 878 citations

ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents

Elizabeth J. Mayer‐Davis, Anna R. Kahkoska, Craig Jefferies et al. · Pediatric Diabetes · 2018 · 680 citations · Full text

Diabetes Management, Diabetes Epidemiology, Adolescent Medicine +7

Multifaceted Determinants for Achieving Glycemic Control

Juliana C.N. Chan, Juan José Gagliardino, Sei Hyun Baik et al. · Diabetes Care · 2008 · 279 citations · Full text

Usefulness of Measuring Both Body Mass Index and Waist Circumference for the Estimation of Visceral Adiposity and Related Cardiometabolic Risk Profile (from the INSPIRE ME IAA Study)

Julie‐Anne Nazare, Jessica Smith, Anne‐Laure Borel et al. · The American Journal of Cardiology · 2014 · 171 citations

Obesity, Metabolic Syndrome, Waist Circumference +11

Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes

Pablo Aschner, H. L. Katzeff, Hongquan Guo et al. · Diabetes Obesity and Metabolism · 2009 · 155 citations · Full text